메뉴 건너뛰기




Volumn 36, Issue 1, 2005, Pages 84-95

Development of humanized antibodies as cancer therapeutics

Author keywords

Cancer therapy; CDR grafting; Epratuzumab; Immunoconjugates; Labetuzumab; Monoclonal antibody

Indexed keywords

ALEMTUZUMAB; BEVACIZUMAB; CARCINOEMBRYONIC ANTIBODY; CETUXIMAB; CHIMERIC ANTIBODY; EPRATUZUMAB; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; LABETUZUMAB; RADIOACTIVE IODINE; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; UNCLASSIFIED DRUG; YTTRIUM 90;

EID: 17644386490     PISSN: 10462023     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymeth.2005.01.008     Document Type: Article
Times cited : (46)

References (67)
  • 18
    • 85030801882 scopus 로고    scopus 로고
    • US Patent Application No. 20040137000 (2004)
    • S. Lynn, C.Y. Wang, US Patent Application No. 20040137000 (2004)
    • Lynn, S.1    Wang, C.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.